• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脂质的纳米系统推动医学发展——脂质体的成功案例。

Advancing Medicine with Lipid-Based Nanosystems-The Successful Case of Liposomes.

作者信息

Luiz Hugo, Oliveira Pinho Jacinta, Gaspar Maria Manuela

机构信息

Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.

出版信息

Biomedicines. 2023 Feb 2;11(2):435. doi: 10.3390/biomedicines11020435.

DOI:10.3390/biomedicines11020435
PMID:36830971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9953160/
Abstract

Nanomedicine, a promising area of medicine, employs nanosized tools for the diagnosis, prevention, and treatment of disease. Particularly, liposomes, lipid-based nanovesicles, are currently one of the most successful nanosystems, with extensive applications in the clinic and an increasing pipeline of products in preclinical and clinical development. These versatile nanotechnological tools are biocompatible and biodegradable, and can load a variety of molecules and, ultimately, improve the therapeutic performance of drugs while minimizing undesired side effects. In this review, we provide a brief description on liposomes' composition and classification and mainly focus on their clinical use in various areas, including disease management (e.g., cancer, fungal and bacterial infections, ocular pathologies), analgesia, vaccination, diagnostics, and immunosuppression in organ transplantation. Herein are described examples of current liposomal products already in the clinic, as well as the most recent clinical trials involving liposomes as effective and safe nanomedicine tools.

摘要

纳米医学是一个很有前景的医学领域,它使用纳米级工具来诊断、预防和治疗疾病。特别是脂质体,一种基于脂质的纳米囊泡,目前是最成功的纳米系统之一,在临床上有广泛应用,并且在临床前和临床开发阶段的产品管线也在不断增加。这些多功能的纳米技术工具具有生物相容性和可生物降解性,能够装载多种分子,并最终在将不良副作用降至最低的同时提高药物的治疗效果。在这篇综述中,我们简要介绍了脂质体的组成和分类,并主要关注它们在各个领域的临床应用,包括疾病管理(如癌症、真菌和细菌感染、眼部疾病)、镇痛、疫苗接种、诊断以及器官移植中的免疫抑制。本文介绍了目前已在临床应用的脂质体产品实例,以及涉及脂质体作为有效且安全的纳米医学工具的最新临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/9953160/6061eeec577e/biomedicines-11-00435-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/9953160/a316bda276be/biomedicines-11-00435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/9953160/b5549653dfb2/biomedicines-11-00435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/9953160/6061eeec577e/biomedicines-11-00435-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/9953160/a316bda276be/biomedicines-11-00435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/9953160/b5549653dfb2/biomedicines-11-00435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/9953160/6061eeec577e/biomedicines-11-00435-g003.jpg

相似文献

1
Advancing Medicine with Lipid-Based Nanosystems-The Successful Case of Liposomes.基于脂质的纳米系统推动医学发展——脂质体的成功案例。
Biomedicines. 2023 Feb 2;11(2):435. doi: 10.3390/biomedicines11020435.
2
(Phospho)lipid-based Nanosystems for Skin Administration.用于皮肤给药的(磷酸)脂质基纳米系统。
Curr Pharm Des. 2015;21(29):4174-92. doi: 10.2174/1381612821666150901095838.
3
Nanodrugs used in cancer therapy.用于癌症治疗的纳米药物。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Jun;163(2):122-131. doi: 10.5507/bp.2019.010. Epub 2019 Apr 9.
4
Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.脂质体:从临床确立的药物传递系统到治疗诊断纳米医学的纳米颗粒平台。
Acc Chem Res. 2011 Oct 18;44(10):1094-104. doi: 10.1021/ar200105p. Epub 2011 Aug 3.
5
Nanovesicles for Nanomedicine: Theory and Practices.用于纳米医学的纳米囊泡:理论与实践
Methods Mol Biol. 2019;2000:1-17. doi: 10.1007/978-1-4939-9516-5_1.
6
Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona.临床批准的脂质体纳米药物:从生物分子冠层中吸取的经验教训。
Nanoscale. 2018 Mar 1;10(9):4167-4172. doi: 10.1039/c7nr07450f.
7
Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation.先进的纳米医学与癌症:临床转化中的挑战与机遇。
Int J Pharm. 2021 Apr 15;599:120438. doi: 10.1016/j.ijpharm.2021.120438. Epub 2021 Mar 2.
8
Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions.用于眼部炎症治疗的新型纳米系统:当前范例和未来研究方向。
J Control Release. 2017 Dec 28;268:19-39. doi: 10.1016/j.jconrel.2017.07.035. Epub 2017 Jul 27.
9
[Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].利用金纳米颗粒开发药物递送技术与纳米医学
Yakugaku Zasshi. 2021;141(3):323-326. doi: 10.1248/yakushi.20-00179-3.
10
Fluorescent Nanosystems for Drug Tracking and Theranostics: Recent Applications in the Ocular Field.用于药物追踪与诊疗的荧光纳米系统:眼部领域的最新应用
Pharmaceutics. 2022 Apr 28;14(5):955. doi: 10.3390/pharmaceutics14050955.

引用本文的文献

1
Novel Strategies for the Formulation of Poorly Water-Soluble Drug Substances by Different Physical Modification Strategies with a Focus on Peroral Applications.通过不同物理改性策略制备难溶性药物的新策略,重点关注口服应用。
Pharmaceuticals (Basel). 2025 Jul 23;18(8):1089. doi: 10.3390/ph18081089.
2
A Liposomal Strategy for Dual-Action Therapy in Sarcopenia: Co-Delivery of Caffeine and HAMA.一种用于少肌症双效治疗的脂质体策略:咖啡因与透明质酸微球的共递送
Int J Mol Sci. 2025 Jun 24;26(13):6031. doi: 10.3390/ijms26136031.
3
DMPC-Based Liposomal Vesicles for Encapsulation and Controlled Release of NMN and Matrigel in Sarcopenia Therapy.

本文引用的文献

1
Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by and Helps Control the Phagosomal Replicative Niches.脂质体传递沙奎那韦至巨噬细胞可克服 和 对组织蛋白酶的阻断作用,有助于控制吞噬体复制龛。
Int J Mol Sci. 2023 Jan 6;24(2):1142. doi: 10.3390/ijms24021142.
2
Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management.用于黑色素瘤治疗的载于脂质体中的新型杂合分子的临床前验证
Biomed Pharmacother. 2023 Jan;157:114021. doi: 10.1016/j.biopha.2022.114021. Epub 2022 Nov 16.
3
Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics.
基于二肉豆蔻酰磷脂酰胆碱的脂质体囊泡用于在少肌症治疗中封装和控释烟酰胺单核苷酸及基质胶
Int J Mol Sci. 2025 Jun 11;26(12):5594. doi: 10.3390/ijms26125594.
4
Nanocarrier-mediated cancer therapy with cisplatin: .纳米载体介导的顺铂癌症治疗:
Heliyon. 2024 Mar 27;10(7):e28171. doi: 10.1016/j.heliyon.2024.e28171. eCollection 2024 Apr 15.
5
Nebulized Hybrid Nanoarchaeosomes: Anti-Inflammatory Activity, Anti-Microbial Activity and Cytotoxicity on A549 Cells.雾化混合纳米古脂质体:对A549细胞的抗炎活性、抗菌活性及细胞毒性
Int J Mol Sci. 2025 Jan 4;26(1):392. doi: 10.3390/ijms26010392.
6
Innovative Approaches to Enhancing the Biomedical Properties of Liposomes.增强脂质体生物医学特性的创新方法。
Pharmaceutics. 2024 Nov 27;16(12):1525. doi: 10.3390/pharmaceutics16121525.
7
Liposome-Assisted Drug Delivery in the Treatment of Multiple Sclerosis.脂质体辅助药物递送在多发性硬化症治疗中的应用。
Molecules. 2024 Oct 3;29(19):4689. doi: 10.3390/molecules29194689.
8
Synergistic delivery of hADSC-Exos and antioxidants has inhibitory effects on UVB-induced skin photoaging.人脂肪间充质干细胞外泌体(hADSC-Exos)与抗氧化剂的协同递送对紫外线B(UVB)诱导的皮肤光老化具有抑制作用。
Heliyon. 2024 Jul 9;10(15):e34321. doi: 10.1016/j.heliyon.2024.e34321. eCollection 2024 Aug 15.
9
Liposomal Rifabutin-A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant Infections.脂质体利福布汀——一种针对耐甲氧西林感染的有前景的抗生素重新利用策略。
Pharmaceuticals (Basel). 2024 Apr 8;17(4):470. doi: 10.3390/ph17040470.
10
Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents.通过将合成磷脂囊泡与透明质酸和渗透保护剂联合应用来增强拉坦前列素的降压作用。
Drug Deliv Transl Res. 2024 Oct;14(10):2804-2822. doi: 10.1007/s13346-024-01584-z. Epub 2024 Apr 11.
脂质纳米颗粒作为吸入疗法的给药载体
Biomedicines. 2022 Sep 2;10(9):2179. doi: 10.3390/biomedicines10092179.
4
Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model.新型锌(II)配合物脂质体制剂在小鼠结肠癌模型中具有高治疗潜力。
Int J Mol Sci. 2022 Jun 16;23(12):6728. doi: 10.3390/ijms23126728.
5
New iron(III) anti-cancer aminobisphenolate/phenanthroline complexes: Enhancing their therapeutic potential using nanoliposomes.新型铁(III)抗癌氨基双酚/菲咯啉配合物:利用纳米脂质体提高其治疗潜力。
Int J Pharm. 2022 Jul 25;623:121925. doi: 10.1016/j.ijpharm.2022.121925. Epub 2022 Jun 16.
6
Liposomes: structure, composition, types, and clinical applications.脂质体:结构、组成、类型及临床应用。
Heliyon. 2022 May 13;8(5):e09394. doi: 10.1016/j.heliyon.2022.e09394. eCollection 2022 May.
7
cRGD Urokinase Liposomes for Thrombolysis in Rat Model of Acute Pulmonary Microthromboembolism.载 cRGD 尿激酶脂质体治疗急性肺微血栓栓塞症大鼠模型的溶栓作用。
Drug Des Devel Ther. 2022 Mar 25;16:801-816. doi: 10.2147/DDDT.S351021. eCollection 2022.
8
Liposomes as Tools to Improve Therapeutic Enzyme Performance.脂质体作为改善治疗性酶性能的工具。
Pharmaceutics. 2022 Feb 27;14(3):531. doi: 10.3390/pharmaceutics14030531.
9
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.单剂量脂质体两性霉素 B 治疗隐球菌性脑膜炎。
N Engl J Med. 2022 Mar 24;386(12):1109-1120. doi: 10.1056/NEJMoa2111904.
10
A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives.脂质体作为药物传递系统的综述:已批准产品的现状、监管环境和未来展望。
Molecules. 2022 Feb 17;27(4):1372. doi: 10.3390/molecules27041372.